Description

3-Quinolinecarboxylic Acid, 1-Cyclopropyl-6-Fluoro-1,4-Dihydro-8-Methoxy-7-(2-Methyl-1-Piperazinyl)-4-Oxo-, Sodium Salt (1:1) is a high-purity pharmaceutical intermediate of significant commercial importance. This compound is a key synthetic precursor in the development of advanced fluoroquinolone antibiotics, valued for its precise chemical structure and reactivity. It is primarily required by research institutions and manufacturers in the pharmaceutical and fine chemical sectors for the synthesis of novel antibacterial agents.

Application

• Pharmaceutical Intermediate: Critical building block for the synthesis of next-generation fluoroquinolone antibiotics.
• Active Pharmaceutical Ingredient (API) Development: Used in research and process development for new antibacterial drug candidates.
• Chemical Synthesis: Serves as a versatile intermediate in complex organic synthesis for modifying quinoline-based structures.
• Biochemical Research: Employed in studies targeting bacterial DNA gyrase and topoisomerase IV enzymes.
• Process Chemistry: Utilized in scale-up and optimization of manufacturing routes for antibiotic production.
• Reference Standard: Can be supplied as a high-purity standard for analytical method development and quality control.

Basic Information

Product Name	3-Quinolinecarboxylic Acid, 1-Cyclopropyl-6-Fluoro-1,4-Dihydro-8-Methoxy-7-(2-Methyl-1-Piperazinyl)-4-Oxo-, Sodium Salt (1:1)
CAS No.	1219097-39-8
Molecular Formula	C19H21FN3NaO4
Molecular Weight	397.38 g/mol
Synonyms	1-Cyclopropyl-6-fluoro-8-methoxy-7-[(2-methyl-1-piperazinyl)]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid sodium salt; Sodium 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(2-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylate; Garenoxacin intermediate sodium salt; Garenoxacin sodium salt intermediate; 7-(2-Methylpiperazin-1-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid sodium salt; BMS-284756 intermediate sodium salt; T-3811 intermediate sodium salt
EINECS	Contact for details

Quality Control

Our 3-Quinolinecarboxylic Acid, 1-Cyclopropyl-6-Fluoro-1,4-Dihydro-8-Methoxy-7-(2-Methyl-1-Piperazinyl)-4-Oxo-, Sodium Salt (1:1) is manufactured under strict quality management systems. The product undergoes rigorous analytical testing to ensure it meets the high-purity standards required for pharmaceutical intermediate applications. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided with each batch and are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and light-sensitive; containers must be kept tightly sealed to minimize exposure to atmospheric moisture and light to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms
Identification (HPLC)	Conforms
Assay (HPLC)	≥98.0%
Water Content (KF)	≤2.0%
Residue on Ignition	≤0.5%
Heavy Metals	≤20 ppm
Related Substances (HPLC)	Total impurities ≤2.0% Any single impurity ≤1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.